First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Astrana Health: the setup is constructive — Medical loss ratio (MLR) performance - ability to keep medical costs at 82-88% of capitated revenue versus budget
value/turnaround - The 50% one-year decline, 0.3x P/S, and 14.8x EV/EBITDA suggest deep value investors betting on margin recovery…
Rising rates create moderate headwinds through two channels: (1) Higher discount rates compress valuation multiples for growth-oriented…
Watch on earnings: CMS Medicare Advantage benchmark rate changes (annual announcements in April) - directly impacts 70%+ of revenue base, Monthly medical loss ratio trends by geography - early warning indicator of cost pressures before quarterly earnings, Physician attrition rates and primary care physician net additions - measures network stability and organic growth capacity.
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $4.0B to $4.4B as medical loss ratio (mlr) performance - ability to keep medical costs at 82-88% of capitated revenue versus budget.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.